Stay on top of every market-moving event with our comprehensive calendar. Earnings, product launches, and shareholder meetings tracked and alerted so no important date slips through. Never miss important events again.
Bio-Rad Laboratories (BIO) has seen a sharp uptick in recent trading, with shares climbing approximately 13.85% to $281.82. This move appears to be accompanied by above-average volume, suggesting strong conviction behind the rally. The stock is now trading well above its near-term support level of $
Is Bio-Rad (BIO) Still a Buy After +13.85% Rally? 2026-05-18 - Social Trading Insights
BIO - Stock Analysis
4229 Comments
1062 Likes
1
Xenova
Active Contributor
2 hours ago
Broad indices show resilience despite sector-specific declines.
👍 153
Reply
2
Koehn
Power User
5 hours ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
👍 282
Reply
3
Demarco
Elite Member
1 day ago
If only I had checked this sooner.
👍 293
Reply
4
Athanasios
Insight Reader
1 day ago
This feels like a serious situation.
👍 79
Reply
5
Jalaal
Power User
2 days ago
Investor focus remains on fundamentals, with sentiment fluctuating in response to recent reports.
👍 137
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.